标题:Restoration of chemosensitivity in cancer cells with MDR phenotype by deoxyribozyme, compared with ribozyme
作者:Xing,A.-Y.;Shi,D.-B.;Liu,W.;Chen,X.;Sun,Y.-L.;Wang,X.;Zhang,J.-P.;Gao,P.
作者机构:[Xing, A.-Y] Department of Pathology, School of Medicine, Shandong University, Jinan 250012, China;[ Shi, D.-B] Department of Pathology, School of Med 更多
通讯作者:Zhang, JP
通讯作者地址:[Zhang, JP]Shandong Univ, Sch Med, Dept Pathol, Jinan 250012, Peoples R China.
来源:Experimental & Molecular Pathology
出版年:2013
卷:94
期:3
页码:481-485
DOI:10.1016/j.yexmp.2013.03.004
关键词:ASODN;Multidrug resistance;P-glycoprotein;Suppress;Transfection
摘要:One of the main mechanisms for multidrug resistance (MDR) involves multidrug resistance gene 1 (MDR1) which encodes P-glycoprotein (Pgp). Pgp acts as a drug efflux pump and exports chemotherapeutic agents from cancer cells. Specific inhibition of Pgp expression by gene therapy is considered a well-respective strategy having less innate toxicities. At present, the investigation of DRz in reversal MDR is scarce. In the study, phosphorothioate DRz that targets to the translation initiation codon AUG was synthesized and transfected into breast cancer cells and leukemia cells with MDR phenotype. ASODN (antisense oligonucleotide) and ribozyme targets to the same region were also synthesized for comparison analysis. Alterations in MDR1 mRNA and Pgp were determined by RT-PCR, Northern blot, flow cytometry and Rh123 retention tests. Chemosensitivity of the treated cells was determined by MTT assay. The results showed that DRz could significantly suppress expression of MDR1 mRNA and inhibit synthesis of Pgp. The efflux activity of Pgp was inhibited accordingly. Chemosensitivity assay showed that a 21-fold reduction in drug resistance for Adriamycin and a 45-fold reduction in drug resistance for Vinblastine were found in the treated cells 36. h after transfection. These data suggest that DRz targeted to the translation initiation codon AUG can reverse MDR phenotype in cancer cells and restore their chemosensitivity. Moreover, the reversal efficiency of DRz is better than that of ribozyme and ASODN targets to the same region of MDR1 mRNA.
收录类别:SCOPUS;SCIE
WOS核心被引频次:12
Scopus被引频次:13
资源类型:期刊论文
原文链接:https://www.scopus.com/inward/record.uri?eid=2-s2.0-84876314293&doi=10.1016%2fj.yexmp.2013.03.004&partnerID=40&md5=2d588531b4578972be9fd8847732e458
TOP